Timo Jahnukainen

Timo Jahnukainen

Auto-generated profile, based on publicly available information

Timo Jahnukainen

Department of Pediatric Nephrology and Transplantation, New Children’s Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
TJTimo Jahnukainen
Timo Jahnukainen
MAMarja Ala-Houhala
Marja Ala-Houhala
RKRiitta Karikoski
Riitta Karikoski
JKJanne Kataja
Janne Kataja
VSVille Saarela
Ville Saarela
MNMatti Nuutinen
Matti Nuutinen

9 February 2016 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
TJTimo Jahnukainen
Timo Jahnukainen
ABAnna Bjerre
Anna Bjerre
MLMarie Larsson
Marie Larsson
JTJuuso Tainio
Juuso Tainio
HTHelle C. Thiesson
Helle C. Thiesson
LWLars Wennberg
Lars Wennberg

1 December 2023 in Hepatology Communications
Verified
Journal Article
Open access
INIiris Nyholm
Iiris Nyholm
NSNelli Sjöblom
Nelli Sjöblom
MPMarjut Pihlajoki
Marjut Pihlajoki
MHMaria Hukkinen
Maria Hukkinen
JLJouko Lohi
Jouko Lohi
MPMikko Pakarinen
Mikko Pakarinen
Background: We aimed to quantify ductular reaction (DR) in biliary atresia using a neural network in relation to underlying pathophysiology and prognosis. Methods: Image-processing neural network model was applied to 259 cytokeratin-7–stained native liver biopsies of patients with biliary atresia and 43 controls. The model quantified total proportional DR (DR%) composed of portal biliary epithelium (BE%) and parenchymal intermediate hepatocytes (PIH%). The results were related to clinical data, Sirius Red–quantified liver fibrosis, serum biomarkers, and bile acids. Results: In total, 2 biliary atresia biopsies were obtained preoperatively, 116 at Kasai portoenterostomy (KPE) and 141 during post-KPE follow-up. DR% (8.3% vs. 5.9%, p=0.045) and PIH% (1.3% vs. 0.6%, p=0.004) were increased at KPE in patients remaining cholestatic postoperatively. After KPE, patients with subsequent liver transplantation or death showed an increase in DR% (7.9%–9.9%, p = 0.04) and PIH% (1.6%–2.4%, p = 0.009), whereas patients with native liver survival (NLS) showed decreasing BE% (5.5%–3.0%, p = 0.03) and persistently low PIH% (0.9% vs. 1.3%, p = 0.11). In Cox regression, high DR predicted inferior NLS both at KPE [DR% (HR = 1.05, p = 0.01), BE% (HR = 1.05, p = 0.03), and PIH% (HR = 1.13, p = 0.005)] and during follow-up [DR% (HR = 1.08, p<0.0001), BE% (HR = 1.58, p = 0.001), and PIH% (HR = 1.04, p = 0.008)]. DR% correlated with Sirius red–quantified liver fibrosis at KPE (R = 0.47, p<0.0001) and follow-up (R = 0.27, p = 0.004). A close association between DR% and serum bile acids was observed at follow-up (R = 0.61, p<0.001). Liver fibrosis was not prognostic for NLS at KPE (HR = 1.00, p = 0.96) or follow-up (HR = 1.01, p = 0.29). Conclusions: DR predicted NLS in different disease stages before transplantation while associating with serum bile acids after KPE.

11 September 2017 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
SRSari H. Rytkönen
Sari H. Rytkönen
PKPetri Kulmala
Petri Kulmala
HAHelena Autio-Harmainen
Helena Autio-Harmainen
PAPekka Arikoski
Pekka Arikoski
KEKira Endén
Kira Endén
TJTimo Jahnukainen
Timo Jahnukainen

17 April 2018 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
TJT. Jahnukainen
T. Jahnukainen
JKJ. Keski‐Nisula
J. Keski‐Nisula
JTJ. Tainio
J. Tainio
HVH. Valkonen
H. Valkonen
TPT. Pätilä
T. Pätilä
PSP. Suominen
P. Suominen

2 January 2023 in Pediatric Transplantation
Verified
Journal Article
Open access
RSRebekka Salonen
Rebekka Salonen
TJTimo Jahnukainen
Timo Jahnukainen
ANAtte Nikkilä
Atte Nikkilä
KEKira Endén
Kira Endén
Background: The present study aimed at investigating long‐term mortality of patients who underwent solid organ transplantation during childhood and at identifying their causes of death.Methods: A cohort of 233 pediatric solid organ transplant recipients who had a kidney, liver, or heart transplantation between 1982 and 2015 in Finland were studied. Year of birth‐, sex‐, and hometown‐matched controls (n = 1157) were identified using the Population Register Center registry. The Causes of Death Registry was utilized to identify the causes of death.Results: Among the transplant recipients, there were 60 (25.8%) deaths (median follow‐up 18.0 years, interquartile range of 11.0–23.0 years). Transplant recipients' risk of death was nearly 130‐fold higher than that of the controls (95% CI 51.9–1784.6). The 20‐year survival rates for kidney, liver, and heart recipients were 86.1% (95% CI 79.9%–92.3%), 58.5% (95% CI 46.2%–74.1%), and 61.4% (95% CI 48.1%–78.4%), respectively. The most common causes of death were cardiovascular diseases (23%), infections (22%), and malignancies (17%). There were no significant differences in survival based on sex or transplantation era.Conclusion: The late mortality is still significantly higher among pediatric solid organ recipients in comparison with controls. Cardiovascular complications, infections, and cancers are the main causes of late mortality for all studied transplant groups. These findings emphasize the cruciality of careful monitoring of pediatric transplant recipients in order to reduce long‐term mortality.